ALNY Alnylam Pharmaceuticals Inc

held by 1 manager in Q3 2022

Manager	% of their portfolio	Held	Activity	Value	Shares
Stanley Druckenmiller Duquesne Family Office	1.02%	3 mo	NEW	$18M	88,910

Search